Sanofi

Agreement includes upfront payment of $20 million with the potential for $1 billion in milestone-based payments plus tiered royalties Atomwise, a…

Yseop, the world-leading AI software company and pioneer in Natural Language Processing (NLP), announced that Sanofi, the global healthcare company,…

Aqemia, the next-gen pharmatech company leveraging artificial intelligence and quantum physics announced, that it has entered a new research…

Sanofi announces the launch of its first Digital Accelerator to foster its ambition to become a leading digital healthcare company. The Accelerator…

Sanofi teams up with McLaren Racing to accelerate industrial excellence Sanofi announces that it is partnering with McLaren Racing to accelerate…

* Collaborative efforts aim to accelerate drug discovery and improve clinical success * Agreement to utilize Exscientia’s AI-based capabilities and…

Second Dupixent (dupilumab) Phase 3 eosinophilic esophagitis trial to demonstrate significant disease improvements, underscoring role of type 2…

Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics development Accelerates development of…

The Focus of the Project Is to Tackle Asthma, a Major Chronic Condition Affecting More Than 340 Million People Globally CytoReason, an AI…

Sanofi, Capgemini, Generali and Orange announce the creation of a digital ecosystem dedicated to e-health, a first in Europe Sanofi, Capgemini,…